Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 191,203 | 195,999 | 170,992 | 150,042 | 121,463 |
| Cost of Goods | 14,725 | 12,329 | 11,912 | 13,448 | 9,789 |
| Gross Profit | 176,478 | 183,670 | 159,080 | 136,594 | 111,674 |
| Operating Expenses | 240,560 | 210,956 | 206,101 | 173,756 | 169,445 |
| Operating Income | -63,357 | -26,957 | -46,109 | -36,714 | -56,982 |
| Interest Expense | 1,185 | 1,172 | 1,120 | 1,834 | 2,431 |
| Other Income | 0 | 0 | 0 | -10,385 | 0 |
| Pre-tax Income | -64,542 | -28,129 | -47,229 | -48,933 | -59,413 |
| Income Tax | N/A | 430 | N/A | -960 | N/A |
| Net Income Continuous | -64,542 | -28,559 | -47,229 | -47,973 | -59,413 |
| Net Income | $-64,542 | $-28,559 | $-47,229 | $-47,973 | $-59,413 |
| EPS Basic Total Ops | -1.26 | -0.55 | -0.94 | -0.97 | -1.22 |
| EPS Basic Continuous Ops | -1.26 | -0.55 | -0.94 | -0.97 | -1.22 |
| EPS Diluted Total Ops | -1.26 | -0.55 | -0.94 | -0.97 | -1.22 |
| EPS Diluted Continuous Ops | -1.26 | -0.55 | -0.94 | -0.97 | -1.22 |
| EPS Diluted Before Non-Recurring Items | -1.26 | -0.71 | -0.94 | -0.92 | -0.80 |
| EBITDA(a) | $-60,831 | $-24,522 | $-43,540 | $-34,151 | $-54,182 |